Michael Jahnz

Title: Michael Jahnz: Innovator in L-Nucleic Acid Synthesis

Introduction

Michael Jahnz is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biochemistry, particularly in the synthesis of L-nucleic acids. With a total of 3 patents to his name, Jahnz continues to push the boundaries of scientific innovation.

Latest Patents

Jahnz's latest patents include groundbreaking methods for the synthesis of L-nucleic acids. One notable invention is a method for adding one or more L-nucleotides to the 3' end of a first L-nucleic acid. This method involves reacting the L-nucleotides with the first L-nucleic acid in the presence of a protein that exhibits mutant enzymatic activity. This enzymatic activity is capable of adding L-nucleotides to the 3' end of the nucleic acid, utilizing a specific amino acid sequence. Another patent focuses on the enzymatic synthesis of L-nucleic acids, detailing a similar method for adding L-nucleotides in the presence of an enzymatic activity exhibiting moiety.

Career Highlights

Throughout his career, Michael Jahnz has worked with notable companies in the biotechnology sector, including Aptarion Biotech AG and Noxxon Pharma AG. His work in these organizations has contributed to advancements in biotechnological applications and research.

Collaborations

Jahnz has collaborated with esteemed colleagues such as Andreas Pech and Ralf David. These partnerships have fostered innovation and development in his research endeavors.

Conclusion

Michael Jahnz is a distinguished inventor whose work in L-nucleic acid synthesis has paved the way for new scientific advancements. His contributions to the field are invaluable, and his ongoing research promises to yield further innovations in biotechnology.